Plasma membrane targeting by short chain sphingolipids inserted in liposomes improves anti-tumor activity of mitoxantrone in an orthotopic breast carcinoma xenograft model

Lília R. Cordeiro Pedrosa, Gerben A. Koning(Università Cattolica del Sacro Cuore), Marcel Verheij(Radboud University Nijmegen), Thomas Soullié(Erasmus University Rotterdam), Ann L.B. Seynhaeve(Rotterdam University of Applied Sciences), Alexander Eggermont(University Medical Center Utrecht), Timo L.M. ten Hagen(Erasmus MC), Olaf van Tellingen(Dutch Cancer Society)
European Journal of Pharmaceutics and Biopharmaceutics
May 14, 2015
10.1016/j.ejpb.2015.05.003
Cited by 11

Related Papers

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941